Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Drug Abuse and Dependence in the United States
2007/05/01 by Wilson M. Compton, Yonette F. Thomas, Frederick S. Stinson +1 · 35 citations
Medicine · Neuroscience · #Substance Abuse Treatment and Outcomes #Neurotransmitter Receptor Influence on Behavior #Opioid Use Disorder Treatment
paper · doi:10.1001/archpsyc.64.5.566
Abstract
BACKGROUND: Current and comprehensive information on the epidemiology of DSM-IV 12-month and lifetime drug use disorders in the United States has not been available. OBJECTIVES: To present detailed information on drug abuse and dependence prevalence, correlates, and comorbidity with other Axis I and II disorders. DESIGN, SETTING, AND PARTICIPANTS: Face-to-face interviews using the Alcohol Use Disorder and Associated Disabilities Interview Schedule of the National Institute on Alcohol Abuse and Alcoholism in a large representative sample of US adults (N=43093). MAIN OUTCOME MEASURES: Twelve-month and lifetime prevalence of drug abuse and dependence and the associated correlates, treatment rates, disability, and comorbidity with other Axis I and II disorders. RESULTS: Prevalences of 12-month and lifetime drug abuse (1.4% and 7.7%, respectively) exceeded rates of drug dependence (0.6% and 2.6%, respectively). Rates of abuse and dependence were generally greater among men, Native Americans, respondents aged 18 to 44 years, those of lower socioeconomic status, those residing in the West, and those who were never married or widowed, separated, or divorced (all P<.05). Associations of drug use disorders with other substance use disorders and antisocial personality disorder were diminished but remained strong when we controlled for psychiatric disorders. Dependence associations with most mood disorders and generalized anxiety disorder also remained significant. Lifetime treatment- or help-seeking behavior was uncommon (8.1%, abuse; 37.9%, dependence) and was not associated with sociodemographic characteristics but was associated with psychiatric comorbidity. CONCLUSIONS: Most individuals with drug use disorders have never been treated, and treatment disparities exist among those at high risk, despite substantial disability and comorbidity. Comorbidity of drug use disorders with other substance use disorders and antisocial personality disorder, as well as dependence with mood disorders and generalized anxiety disorder, appears to be due in part to unique factors underlying each pair of these disorders studied. The persistence of low treatment rates despite the availability of effective treatments indicates the need for vigorous educational efforts for the public and professionals.
Cited by
- Problem gambling severity and the incidence of Axis I psychopathology among older adults in the general population
- Psychometric and Genetic Architecture of Substance Use Disorder and Behavioral Disinhibition Measures for Gene Association Studies
- Stimulant ADHD medication and risk for substance abuse
- Influence of β-Endorphin on anxious behavior in mice: interaction with EtOH
- How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment
- Prevalence and correlates of alcohol, cannabis, and tobacco use disorder in DSM-5 generalized anxiety disorder: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III
- A gender perspective of dual diagnosis: a narrative review
- Preliminary study of family accommodation in 4–7 year-olds with anxiety: frequency, clinical correlates, and treatment response
- Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Borderline Personality Disorder
- Addiction and emotions: From distress-regulation loops to affective recovery niches
- 〔388〕クレーンの走行と走行抵抗〔Karl Heinz Huser, Stahl u.Eisen, 1955-4-21, Jg.75, Nr.8, s.485〜499, 図15, 表9〕
- Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. [europepmc]
- Psychiatric disorders in pregnant and postpartum women in the United States. [europepmc]
- Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later. [europepmc]
- Mental health of college students and their non-college-attending peers: results from the National Epidemiologic Study on Alcohol and Related Conditions. [europepmc]
- How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. [europepmc]
- Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. [europepmc]
- Substance abuse in women. [europepmc]
- The role of early life stress as a predictor for alcohol and drug dependence. [europepmc]
- Cognitive behavioral therapy for substance use disorders. [europepmc]
- Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study. [europepmc]
- Prevalence of the addictions: a problem of the majority or the minority? [europepmc]
- Prevalence and Axis I comorbidity of full and partial posttraumatic stress disorder in the United States: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions. [europepmc]
- Does ADHD predict substance-use disorders? A 10-year follow-up study of young adults with ADHD. [europepmc]
- Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions. [europepmc]
- Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence. [europepmc]
- Depression as a disease of modernity: explanations for increasing prevalence. [europepmc]
- Use and abuse of alcohol and illicit drugs in US adolescents: results of the National Comorbidity Survey-Adolescent Supplement. [europepmc]
- Epidemiology of substance use disorders. [europepmc]
- Comorbidity of posttraumatic stress disorder with alcohol dependence among US adults: results from National Epidemiological Survey on Alcohol and Related Conditions. [europepmc]
- DSM-5 criteria for substance use disorders: recommendations and rationale. [europepmc]
- The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings. [europepmc]
- Epidemiology of DSM-5 Drug Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III. [europepmc]
- Substance Use and Associated Health Conditions throughout the Lifespan. [europepmc]
- Sex and gender differences in substance use disorders. [europepmc]
- Impact of COVID-19 Pandemic on College Student Mental Health and Wellness. [europepmc]
Related